People Search
Phones, Emails, Addresses, Background check, Web references
All public info
Like other search engines (Google or Bing) Radaris collects information from public sources.
PN Venugopalan, President, Actis, said that pre-clinical studies of the technology have demonstra-ted that toxicity of the drug in the liver can be substantially reduced.
Due to manufacturing cost advantage, Angiozyme is likely to reduce cancer treatment cost to one-fifth of conventional costs, Active Biologics President PN Venugopalan said.
Angiozyme was found to be very effective in Phase II trials and we have now applied to DCGI for Phase III trials," said PN Venugopalan, president, Actis Biologics.
Due to manufacturing cost advantage, Angiozyme is likely to reduce cancer treatment cost to one-fifth of conventional costs, Active Biologics President PN Venugopalan said.
Once that is in place, then we will look funds for the Indian and the US operations," Actis Biologics president PN Venugopalan told PTI according to this report.
Due to manufacturing cost advantage, Angiozyme is likely to reduce cancer treatment cost to one-fifth of conventional costs, Active Biologics President PN Venugopalan said
PN Venugopalan, President, Actis, said that pre-clinical studies of the technology have demonstra-ted that toxicity of the drug in the liver can be substantially ...
Due to manufacturing cost advantage, Angiozyme is likely to reduce cancer treatment cost to one-fifth of conventional costs, Active Biologics President PN Venugopalan said
P N Venugopalan. Ms. Sami Faazal. Chief Operating Officer. K B Siva Prakash ... P N Venugopalan has an impressive working experience of 40 years. ...
Mumbai Area, India - President, Actis Biologics Pvt LtdView P. N. Venugopalan's professional profile on LinkedIn. LinkedIn is the world's largest business network, helping professionals like P. N. Venugopalan ...
P.N. Venugopalan. PAUSE. loading. Ramani Aiyer. PAUSE. loading... Ramani Aiyer ... P.N. Venugopalan. AUTOPLAY. play. loading. P.N. Venugopalan. AUTOPLAY ...
Search Results pn venugopalan. Actis Biologics starts phase-III trials of cancer drug, 20-SEP-10. Biotech firm Actis Biologics today said that Angiozyme, ...
25 Jun 2009 ... Please find the attached profile of Mr. P.N. Venugopalan with his one photograph. ... P.N. VENUGOPALAN, PRESIDENT OF ACTIS BIOLOGICS PVT. ...
31 Mar 2010 ... Search on the basis of type of transaction, Sector and date.
Mr. P N Venugopalan has an impressive working experience of 40 years. He started off his career at the age of 19 as a Medical Representative in Schering, ...
26 Oct 2009 ... Chungath House,Meladoor P O , Thrissur-680 741,0480-2771684,94479 94085, "Jyothishalayam", Vyttilla.kochi, mail:[email protected] ...
19 Apr 2009 ... Actis Biologics president PN Venugopalan said we want to raise $250 million to invest in Malaysia, $100 million in India and $50 million in ...
Linkedin
UB Group (Biotechnology industry): President, (1983-2005)